To assess whether macrophages in the tumor microenvironment generated the cytoprotective NO, we depleted TAMs in LLC masses by the injection of CL-LIPO in the peritumoral area (48, 55) (Figure S4B in Supplementary Material). The gene discussed is HMGA2; the disease is neoplasm.